Clostridium difficile

Medicina Clinica

Volumn 108, Issue 4, 1997, Pages 146-155

  Betriu Cabeceran, Carmen ^a   Romero Vivas, José ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BACITRACIN; BACTERIAL VACCINE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; COLESTYRAMINE; ERYTHROMYCIN; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; VANCOMYCIN;

BACTERIAL COLONIZATION; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; COLITIS; DIARRHEA; PATHOGENESIS; PSEUDOMEMBRANOUS COLITIS; REVIEW; SYMPTOMATOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; RECURRENCE;

EID: 0031040712     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (135)

1. Hall IC, O'Toole E. Intestinal flora in newborn infant. Am J Dis Child 1935; 49: 390-402.
2. Bartlett JG. Clostridium difficile: History of its role as an entheric pathogen and current state of knowledge about the organism. Clin Infect Dis 1994; 18 (Supl); 265-272.
3. Finney JMT. Gastro-enterostomy for cicatrizing ulcer of the pylorous. Bull Johns Hopkins Hosp 1893; 4: 53-55.
4. Goulston SJM, McGovern VJ. Pseudomembranous colitis. Gut 1965; 6: 207-212.
5. Hummel RP, Altemeier WA, Hill EO. Iatrogenic staphylococcal enterocolitis. Ann Surg 1964; 160: 551-560.
6. Khan MY, Hall WH. Staphylococcal enterocolitis: treatment with oral vancomycin. Ann Intern Med 1966; 65: 1-8.
7. Larson HE, Parry JV, Price AB, Davies DR, Dolby J, Tyrrell DA. Undescribed toxin in pseudomembranous colitis. Br Med J 1977; 1: 1.246-1.248.
8. Tedesco FJ, Barton RW, Alpers DH. Clindamycin-associated colitis. A prospective study. Ann Intern Med 1974; 81: 429-433.
9. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977; 136: 701-705.
10. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978; 298: 531-534.
11. Bartlett JG, Chang TW, Taylor NS, Odendork AB. Colitis induced by Clostridium difficile. Rev Infect Dis 1979; 1: 370-378.
12. Bartlett JG, Moon N, Chang TW, Taylor NS, Odendork AB. Role of Clostridium difficile in antibiotic associated pseudomembranous colitis. Gastroenterology 1978; 75: 778-782.
13. George RH, Simonds JM, Dimock F, Brown JD, Arabi Y, Shingawa N et al. Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J 1978: 1: 695.
14. George WL, Goldstein EJC, Sutter VL, Ludwig SL, Finegold SM. Etiology of antimicrobial-agent associated colitis. Lancet 1978; 1: 802-803.
15. Larson HE, Price AB. Pseudomembranous colitis: presence of clostridial toxin. Lancet 1977; 2: 1.312-1.314.
16. Rifkin GD, Silva Jr J, Fekety FR, Sack RB. Antibiotic induced colitis. Implication of a toxin neutralized by Clostridium sordellii antitoxin. Lancet 1977; 2: 1.103-1.106.
17. Rifkin GD, Fekety R, Silva J. Neutralization by Clostridium sordellii antitoxin of toxins implicated in clindamycin-induced cecitis in the hamster Gastroenterology 1978; 75: 422-424.
18. Rifkin TD, Silva Jr J, Fekety R. Gastrointestinal and systemic toxicity of fecal extracts from hamsters with clindamycin-induced colitis. Gastroenterology 1978; 74: 52-57.
19. Allo M, Silva Jr J, Fekety R, Rifkin GD, Waskin H. Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin. Gastroenterology 1979; 76: 352-355.
20. Lyerly DM, Krivan HC, Wilkins TD. Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1988; 1 1-18.
21. Fekety R, Akshay B, Shah B. Diagnosis and treatment of Clostridium difficile colitis. JAMA 1993; 269: 71-75.
22. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hosoitalized patients. J Infect Dis 1990; 162: 678-684.
23. Borriello SP, Honour P, Turner T, Barclay F. Household pets as a potential reservoir for Clostridium difficile infection. J Clin Pathol 1983; 36: 84-87.
24. Kaatz GW, Gitlin SD, Schaberg DR, Wilson KH, Kauffman CA, Seo SM et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988; 127: 1 289-1 294.
25. McFarland LV, Mulligan ME, Kwok RYY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320: 204-210.
26. Samore MH, DeGirolami PC, Tlucko A, Lichtenberg DA, Melvin ZA, Karchmer AW. Clostridium difficile colonization and diarrhea at a terciary care hospital. Clin Infect Dis 1994; 18: 181-187.
27. Struelens MJ, Moos A, Nonhoff C, Deplano A, Rost F, Serruyo E et al. Control of nosocomial transmission of Clostridium difficile based on sporadic case surveillance. Am J Med 1991; 91 Suppl 3B: 138S-144S.
28. Johnson S, Gerding DN, Olson MM, Weiler MD, Hughes RA, Clabots CR et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990; 88: 137-140.
29. Brooks SE, Veal RO, Kramer L, Dore L, Schupf N, Adachi M. Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables. Infect Control Hosp Epidemiol 1992; 13: 98-103.
30. Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonization and disease: Lancet 1990; 336: 97-100.
31. Simor AE, Yake SL, Tsimidis K. Infection due to Clostridium difficile among elderly residents of a long-term care facility. Clin Infect Dis 1993; 17: 672-678.
32. Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992; 15: 573-578.
33. Strimling Mo, Sacho H, Berkowitz I. Clostridium difficile infection in a healthcare workers. Lancet 1989; 2: 866-867.
34. Delmee M. Clostridium difficile infection in health-care workers. Lancet 1989; 2: 1.095.
35. Thibault A, Miller MA, Gaese C. Risk factors for the development of Clostridium difficile during an hospital outbreak. Infect Control Hosp Epidemiol 1991; 12: 345-348.
36. Bartlett JG. Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea or colitis. Johns Hopkins Med J 1981; 149: 6-9.
37. Nelson DE, Aurbach SB, Baltch AL, Desjardin E, Beck Sague C, Rhead C et al. Epidemic Clostridium difficile-associated diarrhea: role of second and third generation of cephalosporins. Infect Cont Hosp Epidemiol 1994; 15: 87-94.
38. George WL. Antimicrobial agent-associated diarrhea and colitis. En: Finegold SM, George WL, editores. Anaerobic infections in humans. San Diego, CA: Academic Press. Inc., 1989; 661-678.
39. Anglim AM, Farr BM. Nosocomial diarrhea due to Clostridium difficile. Cur Opin Infect Dis 1994; 7: 602-608.
40. Rolfe Rd, Finegold SM. Intestinal β-lactamase activity in ampicillin-induced Clostridium difficile-associated ileocecitis. J Infect Dis 1983; 147: 227-235
41. Larson HE, Welch A. In-vivo and in-vitro characterization of resistance to colonization of Clostridium difficile. J Med Microbiol 1993; 38: 103-108.
42. Chachaty e, Dipitre C, Mario N, Bourniex C, Saulnier P, Corthier C et al. Presence of Clostridium difficile and antibiotic and β-lactamase activities in faeces of volunteers treated with oral cefixime, oral cefpodoxime proxetil or placebo. Antimicrob Agents Chemother 1992; 36: 2.009-2.013.
43. Cledge CL, Carson CF, O'Neil GL, Bowman RA, Riley TV. Ciprofloxacin and Clostridium difficile-associated diarrhea. J Antimicrob Chemother 1992; 30: 141-147.
44. Miller PD, Pothoulakis C, Baeker TR, LaMont JT, Rothstein TL. Macrophage-dependent stimulation of T-cell depleted spleen cells by Clostridium difficile toxin A and calcium ionophore. Cell Immunol 1990; 126: 155-163
45. Moskowitz M, Bartlett JG. Recurrent pseudomembranous colitis unas sociated with prior antibiotic therapy. Arch Intern Med 1981; 141: 663-664.
46. Bartlett JG, Gorbach SL. Pseudomembranous enterocolitis (antibiotic-related colitis). Adv Intern Med 1977; 22: 455-476.
47. Dosik GM, Luna M, Valdivieso M, McCredie KB, Gehan EH, Gil-Extremera B et al. Necrotizing colitis in patients with cancer. Am J Med 1979; 67: 646-656.
48. Bassaris HP, Lianon FE, Legakis NJ, Papavassilon JT. Interaction between Clostridium difficile and polymorphonuclear leukocytes from the elderly and postoperative cancer patients phagocytosis and bactericidal function. Med Microbiol Immunol 1984; 173: 49-55.
49. Nakamura S, Milikawa M, Nakashid S, Takabatake M, Okado I, Yamkula K et al. Isolation of Clostridium difficile from the faeces and antibody in sera of young and elderly adults. Microbiol Immunol 1981; 25: 345.
50. Gryboski JD, Pellerano R, Young N. Positive role of Clostridium difficile infection in diarrhea in infants and children. Am J Gastroenterol 1991; 86: 685-689.
51. Leung DY, Kelly CP, Boguiewicz M, Pothoulakis C, LaMont JT, Flores A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 1991; 118: 633-637.
52. Kelly CP, Pothoulakis C, Orellana J, LaMont JT. Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptors binding. Gastroenterology 1990; 102: 35-40.
53. Cappell MS, Philogene C. Clostridium difficile infection is a treatable case of diarrhea in patients with advanced human immunodeficiency virus infection: a study of seven consecutive patients admitted from 1986 to a University teaching hospital. Am J Gastroenterol 1993; 88: 891-897.
54. Barbur F, Depitre C. Delmée M, Corthier G, Petit JC. Comparison of enterotoxin production, citotoxin production, serogrouping and antimicrobial susceptibilities of Clostridium difficile strains isolated in AIDS and human immunodeficiency-virus negative patients. J Clin Microbiol 1993; 31: 740-743.
55. Taylor NS, Thorne GM, Bartlett JG. Comparison of two toxins produced by Clostridium difficile. Infect Immun 1981; 34: 1.036-1.043.
56. Banno Y, Kobayashi T, Watanabe K, Ueno K, Nozawa Y. Two toxins (D-1 and D-2) of Clostridium difficile causing antibiotic-associated colitis: purification and some characterization. Biochem Int 1981; 2: 629-635.
57. Bartlett JG, Chang TW, Moon N, Onderdomk AB. Antibiotic-induced lethal enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin-producing clostridia. Am J Vet Res 1978; 39: 1.525-1.530.
58. Pothoulakis C, Sullivan R, Melnick D, Triadaphilopoulos G, Gadenne AS, Neshulam T et al. Clostridium difficile toxin A stimulates intracelular calcium release and chemotactic response in human granulocytes. J Clin Invest 1988; 81: 1.741-1.745.
59. Larson HE, Barclay FE, Honour P, Hill ID. Epidemiology of Clostridium difficile in infants. J Infect Dis 1982; 146: 727-733.
60. Eglow R, Pothoulakis C, Itzkowitz S, Israel EJ, O'Keane CJ, Gong D et al. Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor. J Clin Invest 1992; 90: 822-829.
61. Hecht G, Pothoulakis C, LaMont JT, Madara JL. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal ephitelial monolayers. J Clin Invest 1988; 82: 1.516-1.524.
62. Depitre C, Delmée M, Avesani V, L'Haridon R, Roels A, Popoff M, Corthier G, Serogroup F strains of Clostridium difficile produce toxin B but not toxin A. J Med Microbiol 1993; 38: 434-441.
63. Price AB, Davies DR. Pseudomembranous colitis. J Clin Pathol 1977; 30: 1-12.
64. a ed.). Nueva York: Churchill Livingstone, 1995; 978-987.
65. Johnson S, Homan SR, Bettin KM, Quick JN, Clabots Cr, Peterson LR et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole: a randomized, placebo controlled-trial. Ann Intern Med 1992; 117: 297-302.
66. Marx CE, Morris A, Wilson ML, Reller LB. Fecal leukocytes in stool specimens submitted for Clostridium difficile toxin assay. Diagn Microbiol Infect Dis 1993; 16: 313-315.
67. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330: 257-262.
68. Tedesco FJ, Corless JK, Brownstein RE. Rectal sparing in antibiotic-associated pseudomembranous colitis: a prospective study. Gastroenterology 1982; 83: 1.259-1.260.
69. Bradley SJ, Weaver DW, Maxwell NP, Bowman DL. Surgical management of pseudomembranous colitis. An Surg 1988; 54: 329-332.
70. Cartmill TDI, Panigrahi H, Worsley MA, McCann DC, Nice CN, Keith E. Management and control of a large outbreak of diarrhoea due to Clostridium difficile. J Hosp Infect 1994; 27: 1-15.
71. Hafiz S, Morton RS, McEntegart MG, Walkins SA. Clostridium difficile in the urogenital tract of males and females. Lancet 1975; 1: 420-421.
72. Lvett P. Clostridium difficile in habitats other than the human gastro-intestinal tract. J Infect 1986; 12: 253-256.
73. Sagimur R, Fogel R, Begin L, Cohen B, Mendelson J. Splenic abscess due to Clostridium difficile. J Infect Dis 1983; 147: 1.105.
74. Gérard M, Defresne N, Van der Auwera P, Meunier F. Polymicrobial septicemia with Clostridium difficile in acute diverticulitis. Eur J Clin Microbiol Infect Dis 1989; 8: 300-302.
75. Bolton RP, Sherriff RJ, Read AE. Clostridium difficile associated-diarrhoea: a role in inflammatory bowel disease? Lancet 1980; 1: 383-384.
76. Cashore WJ, Peter G, Lavermann M, Stonestreet BS, Oh W. Clostridial colonization and clostridial toxin in neonatal necrotizing enterocolitis. J Pediatr 1981; 98: 308-311.
77. Dorman SA, Lligoria E, Winn WCJr, Breken WL. Isolation of Clostridium difficile from patients with inactive Crohn's disease. Gastroenterology 1982; 82: 1.348-1.352.
78. Han VKM, Sayed H, Chance GW, Brabya DG, Shaheed WA. An outbreak of Clostridium difficile necrotizing enterocolitis: a case for oral vancomycin therapy. Pediatrics 1983; 71: 935-941.
79. Gerding DN. Disease associated with Clostridium difficile. Ann Intern Med 1989; 110: 255-257.
80. Gerding DN, Olson MM, Peterson LR, Teasley DG, Gebhard RL, Schwartz ML et al. Clostridium difficile-associated diarrhea and colitis in adults. Arch Intern Med 1986; 146: 95-100.
81. Gerding DN, Brazier JS. Optimal methods for identifying Clostridium difficile infections. Clin Infect Dis 1993; 16 (Supl 4): 439-442.
82. Borriello SP, Wren BW, Hyde S, Seddon SV, Sibbons P, Krishna MM et al. Molecular, immunological and, biological characterization of a Toxin A-negative, Toxin B-positive strain of Clostridium difficile. Infect Immunol 1992; 60: 4.192-4.199.
83. Peterson LR, Kelly CP. The role of the clinical microbiology laboratory in the management of Clostridium difficile-associated diarrhea. Infect Dis Clin North Am 1993; 7: 277-293.
84. Doern GV, Coughlin RT, Wu L. Laboratory diagnosis of Ciostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays. J Clin Microbiol 1992; 30: 2.042-2.046.
85. Bond F, Payne G, Borriello SP, Humphreys H. Usefulness of culture in the diagnosis of Clostridium difficile infection. Eur J Clin Microbiol Infect Dis 1995; 14: 223-226.
86. Borriello SP, Barclay FE, Reed PJ, Welch AR, Brown JD, Burdon DW. Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between Clostridium difficile toxins A and B and latex reactive protein. J Clin Pathol 1987; 40: 573-580.
87. Kamiya S, Nakamura K, Yamakawa K, Nishida S. Evaluation of a commercially available latex immunoagglutination test kit for detection of Clostridium difficile D-1 toxin. Microbiol Immunol 1986; 30: 177-181.
88. Shanholzer CJ, Willard KE, Holter JJ, Olson MM, Gerding DN, Peterson LR. Comparison of VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests. J Clin Microbiol 1992; 30: 1.837-1.840.
89. Mattia AR, Doern GV, Clark J, Holden J, Wu E, Ferraro MJ. Comparison of four methods in the diagnosis of Clostridium difficile disease. Eur J Clin Microbiol Infect Dis 1993; 12: 882-886.
90. Knapp CC, Sandin RL, Hall GS, Ludwig MD, Rutherfort I, Washington JA. Comparison of VIDAS Clostridium difficile toxin A assay and Premier C. difficile toxin A assay to cytotoxin-B tissue culture assay for the detection of toxins of C. difficile. Diagn Microbiol Infect Dis 1993; 17: 7-12.
91. Borriello SP, Vale T, Brazier JS, Hyde S, Chippek E. Evaluation of a commercial enzyme immunoassay kit for the detection of C. difficile-toxin A. Eur J Clin Microbiol Infect Dis 1992; 11: 360-363.
92. Barbut F, Kajzer C, Planas N, Petit JC. Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile associated diarrhea. J Clin Microbiol 1993; 31: 963-967.
93. George WL, Sutter VL, Citron D, Finegold SM. Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol 1979; 9: 214-219.
94. Niyogi SK, Pal SC. Comparison of selective media for optimal recovery of Clostridium difficile from diarrhoeal stools. Indian J Med Res 1992; 95: 181-183.
95. Hanf PA, Zaleznik DF, Kent KC, Rubin MS, Kelly E, Cote J, Rosol-Donoghe J. Use of heat shock for culturing Clostridium difficile from rectal swabs. Clin Infect Dis 1993; 16 Suppl 4: S245-S247.
96. Aspinall ST, Hutchinson DN. New selective medium for isolating Clostridium difficile from faeces. J Clin Pathol 1992; 45: 812-814.
97. Fekety R, Kim K-H, Brown D, Batts DH, Cudmore M, Silva J Jr. Epidemiology of antibiotic-associated colitis: isolation of Clostridium difficile from the hospital environement. Am J Med 1981; 70: 906-908.
98. Yong WH, Mattia AR, Ferraro MI. Comparison of fecal lactoferrin latex agglutination assay and methylene blue microscopy for detection of fecal leukocytes in Clostridium difficile-associated disease. J Clin Microbiol 1994; 32: 1.360-1.361.
99. Kato N, Ou C-Y, Kato H, Bartley SL, Luo C-C, Killgore CE, Ueno K. Detection of toxigenic Clostridium difficile in stool specimens by the polymerase chain reaction. J Clin Infect 1993; 167: 455-458.
100. Gumerlock PH, Tang YJ, Weiss JB, Silva J Jr. Specific detection of toxigenic strains of Clostridium difficile in stool specimens. J Clin Microbiol 1993; 31: 507-511.
101. Kuhl SJ, Tang YJ, Navarroo L, Gumerlock PH, Silva J Jr. Diagnosis and monitoring of Clostridium difficile with the polymerase chain reaction. Clin Infect Dis 1993; 16 Suppl 4: S234-S238.
102. Kurzynski TA, Kimball JL, Schultz DA, Schell RF. Evaluation of C. dif-CUBE test for detection of Clostridium difficile-associated diarrhea. Diagn Microbiol Infect Dis 1992; 15: 493-498.
103. Wolfhagen MJHM, Fluit AC, Jansze M, Rademaker CMA, Verhoef J. Detection of toxigenic Clostridium difficile in fecal samples by colony blot hybridization. Eur J Clin Microbiol Infect Dis 1993; 167: 455-458.
104. Wolfhagen MJHM, Fluit AC, Torensma R, Poppelier MJJG, Verhoef J. rapid detection of toxigenic Clostridium difficile in fecal samples by magnetic immuno PCR assay. J Clin Microbiol 1994; 32: 1.629-1.633.
105. Delmée M, Depitre C, Corthier G, Ahoyo A, Avesari V. Use of an enzime-linked immunoassay for Clostridium difficile serogrouping. J Clin Microbiol 1993; 31: 2.526-2.528.
106. Wolfhagen MJHM, Fluit AC, Torensma R, Jansze M, Kuypers AFA, Verhage EAE, Verhoef J. Comparison of typing methods for Clostridium difficile isolates. J Clin Microbiol 1993; 31: 2.208-2.211.
107. Clabots CR, Johnson S, Betin KM, Mathie PA, Mulligan ME, Schaberg DR et al. Development of a rapid and efficient restriction endonuclease analysis typing system for C. difficile and correlation with other typing-systems. J Clin Microbiol 1993; 31: 1.870-1.875.
108. Cartmill TDI, Orr K, Freeman R, Sisson PR, Lightfoot NF. Nosocomial infection with Clostridium difficile investigated by pyrolysis mass spectrometry. J Med Microbiol 1992; 37: 352-356.
109. Magee JT, Brazier JS, Hosein JK, Ribiero CD, Hill DV, Griffihts A et al. An investigation of a nosocomial outbreak of Clostridium difficile by pyrolysis mass spectrometry. J Med Microbiol 1993; 39: 345-351.
110. Teasley PG, Gerding DN, Olson MM, Peterson RL, Begbard RL, Schartz MJ et al. Prospective randomized trial of metronidazole versus vancomycin for Clostridium difficile-association diarrhea and colitis. Lancet 1983; 2: 1.043-1.046.
111. Church JM, Fazio VW. A role for colonic stasis in the pathogenesis of disease related to Clostridium difficile. Dis Colon Rectum 1986; 29: 804-809.
112. Saginur R, Hawley CR, Bartlett JG. Colitis associated with metronidazole therapy. J Infect Dis 1980; 141: 772-774.
113. Bouza E. Infection causada por Clostridium difficile. Situación en los 90. Rev Clin Esp 1994; 4: 870-877.
114. Van der Auwesa P, Defresne N, Grenier P, Meunier F. Emergence of resistant (R) E. faecium and coagulase-negative Staph. (CNS) in fecal flora of volunteers (V) receiving oral teicoplanin (T). Abstract 258 from the 30 th Interscience Conference on Antimicrobial agents and Chemotherapy (ICAAC). Atlanta (Georgia) 21-24 de octubre, 1990.
115. De Lalla F, Nicolin R, Rinaldi E, Scarpellini P, Rigoli R, Manfrin V et al. Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea. Antimicrob Agents Chemother 1992; 36: 2.192-2.196.
116. Fekety R, Silva J, Kaufman C, Buggy B, Deery G. Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med 1989; 86: 15-19.
117. Pasic M, Jost R, Carell T, Von Segresser L, Turina M. Intracolonic vancomycin for pseudomembranous colitis. N Engl J Med 1993; 329: 583.
118. Bolton RF, Culsaw MA, Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic-associated colitis due to Clostridium difficile. Gut 1986; 27: 1.169-1.172.
119. Kleinfeld DI, Sharpe RJ, Donta ST. Parenteral therapy for antibiotic-associated pseudomembranous colitis. J Infect Dis 1988; 157: 389.
120. Bergan T, Solhaugh JH, Soreide O, Leinero O. Comparative pharmacokinetics of metronidazole and tinidazole and their tissue penetration. Scand J Gastroenterol 1985; 20: 945-950.
121. Dudley MN, McLaughlin JC, Carrington G, Frick J, Nightingale CH, Quintiliani R. Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea: a randomized double-blind trial Arch Intern Med 1986; 146: 1.101-1.104.
122. Fekety R, Silva J, Toshniwal R, Allo M, Armstron R, Browne J et al. Antibiotic-associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters. Rev Infect Dis 1979; 1: 386-397.
123. Johnson S, Adelmann A, Clabots CR, Peterson RL, Gerding DN. Recurrences of Clostridium difficile diarrhea not caused by the original infected organism. J Infect Dis 1989; 159: 340-343.
124. O'Neil GL, Beaman MH, Riley TV. Relapse versus reinfection with Clostridium difficile. Epidemiol Infect 1991; 107: 627-635.
125. Tedesco FJ, Gordon D, Fortson WC. Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 1985; 80: 867-868.
126. Burbige EJ, Milligan FD. Pseudomembranous colitis association with antibiotics and therapy with cholestyramine. JAMA 1975; 231: 1.157-1.158.
127. Buggy BP, Fekety R, Silva J Jr. Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin. J Clin Gastroenterol 1987; 9: 155-159.
128. Gorbach SL, Chang TW, Goldin B. Succsesful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987; 2: 1.519.
129. Surawicz CM, Elmer GW, Speelman P, McFariand LV, Chin J, van Bell G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96: 981-989.
130. McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GV, Moyer KA et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1984; 271: 1.913-1.918.
131. Schellenberg D, Bonigton A, Champion CM, Lancaster R, Webb S, Main J. Treatment of Clostridium difficile diarrhoea with brewer'yest. Lancet 1994; 343: 171-172.
132. Seal D, Borriello SP, Barclay F, Welch A, Piper M, Bonnycastle M. Treatment of relapsing of Clostridium difficile diarrhoea by administration of a non-toxigenic strain. Eur J Clin Microbiol 1987; 6: 51-53.
133. Twede M, Rask-Madsen J. Bactheriotherapy for chronic-relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989; 1: 1.156-1.160.
134. Lyerly DM. Epidemiology of Clostridium difficile disease. Clin Microbiol Newslet 1993; 15: 49-52.
135. Rutala WA, Gergen MF, Weber D. Inactivation of Clostridium difficile spores by disinfectants. Infect Control Hosp Epidemiol 1993; 14: 36-39.